Clipping of news on Brazilian Culture, Law and Citizenship
 


Consumer News

ANVISA suspends import of pharmaceutical ingredient

03/29/2012

This article was translated by an automatic translation system, and was therefore not reviewed by people.

 


 


The National Health Surveillance Agency (ANVISA) published on Wednesday (28/3) in the Official Gazette (DOU), the suspension of import of pharmaceutical ingredient Clindamycin Hydrochloride.

The manufacturer Zhejiang Candorly Pharmaceutical CO. LTD. does not meet the regulatory requirements of ANVISA.



Press / Anvisa


Source: ANVISA

Our news are taken in full of our partner sites. For this reason, we can not change the content of these up in case of typing errors.

This article was translated by an automatic translation system, and was therefore not reviewed by people.

Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.


  Subjects list
 
  Copyright (c) 2006-2009. JurisWay - All rights reserved.